Inhibition  ||| S:0 E:11 ||| NNP
of  ||| S:11 E:14 ||| IN
FSS-induced  ||| S:14 E:26 ||| JJ
actin  ||| S:26 E:32 ||| JJ
cytoskeleton  ||| S:32 E:45 ||| JJ
reorganization  ||| S:45 E:60 ||| NN
by  ||| S:60 E:63 ||| IN
silencing  ||| S:63 E:73 ||| CD
LIMK2  ||| S:73 E:79 ||| CD
gene  ||| S:79 E:84 ||| NN
increases  ||| S:84 E:94 ||| VBZ
the  ||| S:94 E:98 ||| DT
mechanosensitivity  ||| S:98 E:117 ||| NN
of  ||| S:117 E:120 ||| IN
primary  ||| S:120 E:128 ||| JJ
osteoblasts  ||| S:128 E:140 ||| JJ
Mechanical  ||| S:140 E:151 ||| JJ
stimulation  ||| S:151 E:163 ||| NN
plays  ||| S:163 E:169 ||| VBZ
an  ||| S:169 E:172 ||| DT
important  ||| S:172 E:182 ||| JJ
role  ||| S:182 E:187 ||| NN
in  ||| S:187 E:190 ||| IN
bone  ||| S:190 E:195 ||| NN
cell  ||| S:195 E:200 ||| NN
metabolic  ||| S:200 E:210 ||| NN
activity ||| S:210 E:218 ||| NN
.  ||| S:218 E:220 ||| .
However ||| S:220 E:227 ||| RB
,  ||| S:227 E:229 ||| ,
bone  ||| S:229 E:234 ||| NN
cells  ||| S:234 E:240 ||| NNS
lose  ||| S:240 E:245 ||| VBP
their  ||| S:245 E:251 ||| PRP$
mechanosensitivity  ||| S:251 E:270 ||| NN
upon  ||| S:270 E:275 ||| IN
continuous  ||| S:275 E:286 ||| JJ
mechanical  ||| S:286 E:297 ||| JJ
stimulation  ||| S:297 E:309 ||| NN
( ||| S:309 E:310 ||| -LRB-
desensitization ||| S:310 E:325 ||| LS
)  ||| S:325 E:327 ||| -RRB-
and  ||| S:327 E:331 ||| CC
they  ||| S:331 E:336 ||| PRP
can  ||| S:336 E:340 ||| MD
recover  ||| S:340 E:348 ||| VB
the  ||| S:348 E:352 ||| DT
sensitivity  ||| S:352 E:364 ||| NN
with  ||| S:364 E:369 ||| IN
insertion  ||| S:369 E:379 ||| NN
of  ||| S:379 E:382 ||| IN
appropriate  ||| S:382 E:394 ||| JJ
rest  ||| S:394 E:399 ||| NN
period  ||| S:399 E:406 ||| NN
into  ||| S:406 E:411 ||| IN
the  ||| S:411 E:415 ||| DT
mechanical  ||| S:415 E:426 ||| JJ
loading  ||| S:426 E:434 ||| NN
profiles ||| S:434 E:442 ||| NNS
.  ||| S:442 E:444 ||| .
The  ||| S:444 E:448 ||| DT
concrete  ||| S:448 E:457 ||| JJ
molecular  ||| S:457 E:467 ||| JJ
mechanism  ||| S:467 E:477 ||| NN
behind  ||| S:477 E:484 ||| IN
the  ||| S:484 E:488 ||| DT
regulation  ||| S:488 E:499 ||| NN
of  ||| S:499 E:502 ||| IN
cell  ||| S:502 E:507 ||| NN
mechanosensitivity  ||| S:507 E:526 ||| VBZ
still  ||| S:526 E:532 ||| RB
remains  ||| S:532 E:540 ||| VBZ
unclear ||| S:540 E:547 ||| JJ
.  ||| S:547 E:549 ||| .
As  ||| S:549 E:552 ||| IN
one  ||| S:552 E:556 ||| CD
kind  ||| S:556 E:561 ||| NN
of  ||| S:561 E:564 ||| IN
mechanosensitive  ||| S:564 E:581 ||| JJ
cell  ||| S:581 E:586 ||| NN
to  ||| S:586 E:589 ||| TO
react  ||| S:589 E:595 ||| VB
to  ||| S:595 E:598 ||| TO
the  ||| S:598 E:602 ||| DT
mechanical  ||| S:602 E:613 ||| JJ
stimulation ||| S:613 E:624 ||| NN
,  ||| S:624 E:626 ||| ,
osteoblasts  ||| S:626 E:638 ||| RB
respond  ||| S:638 E:646 ||| VB
to  ||| S:646 E:649 ||| TO
fluid  ||| S:649 E:655 ||| VB
shear  ||| S:655 E:661 ||| JJ
stress  ||| S:661 E:668 ||| NN
( ||| S:668 E:669 ||| -LRB-
FSS ||| S:669 E:672 ||| NNP
)  ||| S:672 E:674 ||| -RRB-
with  ||| S:674 E:679 ||| IN
actin  ||| S:679 E:685 ||| JJ
cytoskeleton  ||| S:685 E:698 ||| JJ
reorganization ||| S:698 E:712 ||| NN
,  ||| S:712 E:714 ||| ,
and  ||| S:714 E:718 ||| CC
the  ||| S:718 E:722 ||| DT
remodeling  ||| S:722 E:733 ||| NN
of  ||| S:733 E:736 ||| IN
actin  ||| S:736 E:742 ||| JJ
cytoskeleton  ||| S:742 E:755 ||| NN
is  ||| S:755 E:758 ||| VBZ
closely  ||| S:758 E:766 ||| RB
associated  ||| S:766 E:777 ||| VBN
with  ||| S:777 E:782 ||| IN
the  ||| S:782 E:786 ||| DT
alteration  ||| S:786 E:797 ||| NN
of  ||| S:797 E:800 ||| IN
cell  ||| S:800 E:805 ||| NN
mechanosensitivity ||| S:805 E:823 ||| NN
.  ||| S:823 E:825 ||| .
In  ||| S:825 E:828 ||| IN
order  ||| S:828 E:834 ||| NN
to  ||| S:834 E:837 ||| TO
find  ||| S:837 E:842 ||| VB
out  ||| S:842 E:846 ||| RP
whether  ||| S:846 E:854 ||| IN
inhibiting  ||| S:854 E:865 ||| VBG
the  ||| S:865 E:869 ||| DT
actin  ||| S:869 E:875 ||| JJ
cytoskeleton  ||| S:875 E:888 ||| JJ
reorganization  ||| S:888 E:903 ||| NN
by  ||| S:903 E:906 ||| IN
silencing  ||| S:906 E:916 ||| JJ
LIM-kinase  ||| S:916 E:927 ||| JJ
2  ||| S:927 E:929 ||| CD
( ||| S:929 E:930 ||| -LRB-
LIMK2 ||| S:930 E:935 ||| NNP
)  ||| S:935 E:937 ||| -RRB-
gene  ||| S:937 E:942 ||| NN
would  ||| S:942 E:948 ||| MD
increase  ||| S:948 E:957 ||| VB
the  ||| S:957 E:961 ||| DT
mechanosensitivity  ||| S:961 E:980 ||| NN
of  ||| S:980 E:983 ||| IN
primary  ||| S:983 E:991 ||| JJ
osteoblasts ||| S:991 E:1002 ||| NN
,  ||| S:1002 E:1004 ||| ,
we  ||| S:1004 E:1007 ||| PRP
attenuated  ||| S:1007 E:1018 ||| VBD
the  ||| S:1018 E:1022 ||| DT
formation  ||| S:1022 E:1032 ||| NN
of  ||| S:1032 E:1035 ||| IN
actin  ||| S:1035 E:1041 ||| JJ
stress  ||| S:1041 E:1048 ||| NN
fiber  ||| S:1048 E:1054 ||| NN
under  ||| S:1054 E:1060 ||| IN
FSS  ||| S:1060 E:1064 ||| NNP
in  ||| S:1064 E:1067 ||| IN
a  ||| S:1067 E:1069 ||| DT
more  ||| S:1069 E:1074 ||| RBR
specific  ||| S:1074 E:1083 ||| JJ
way ||| S:1083 E:1086 ||| NN
:  ||| S:1086 E:1088 ||| :
inhibiting  ||| S:1088 E:1099 ||| VBG
the  ||| S:1099 E:1103 ||| DT
LIMK2  ||| S:1103 E:1109 ||| JJ
expression  ||| S:1109 E:1120 ||| NN
by  ||| S:1120 E:1123 ||| IN
RNA  ||| S:1123 E:1127 ||| NNP
interference ||| S:1127 E:1139 ||| NN
.  ||| S:1139 E:1141 ||| .
We  ||| S:1141 E:1144 ||| PRP
found  ||| S:1144 E:1150 ||| VBD
that  ||| S:1150 E:1155 ||| DT
inhibition  ||| S:1155 E:1166 ||| NN
of  ||| S:1166 E:1169 ||| IN
LIMK2  ||| S:1169 E:1175 ||| CD
expression  ||| S:1175 E:1186 ||| NN
by  ||| S:1186 E:1189 ||| IN
RNA  ||| S:1189 E:1193 ||| NNP
interference  ||| S:1193 E:1206 ||| NN
attenuated  ||| S:1206 E:1217 ||| VBD
the  ||| S:1217 E:1221 ||| DT
formation  ||| S:1221 E:1231 ||| NN
of  ||| S:1231 E:1234 ||| IN
FSS-induced  ||| S:1234 E:1246 ||| JJ
actin  ||| S:1246 E:1252 ||| JJ
stress  ||| S:1252 E:1259 ||| NN
fiber ||| S:1259 E:1264 ||| NN
,  ||| S:1264 E:1266 ||| ,
and  ||| S:1266 E:1270 ||| CC
simultaneously  ||| S:1270 E:1285 ||| RB
maintained  ||| S:1285 E:1296 ||| VBN
the  ||| S:1296 E:1300 ||| DT
integrity  ||| S:1300 E:1310 ||| NN
of  ||| S:1310 E:1313 ||| IN
actin  ||| S:1313 E:1319 ||| JJ
cytoskeleton  ||| S:1319 E:1332 ||| NN
in  ||| S:1332 E:1335 ||| IN
primary  ||| S:1335 E:1343 ||| JJ
osteoblasts ||| S:1343 E:1354 ||| NN
.  ||| S:1354 E:1356 ||| .
We  ||| S:1356 E:1359 ||| PRP
confirmed  ||| S:1359 E:1369 ||| VBD
that  ||| S:1369 E:1374 ||| IN
the  ||| S:1374 E:1378 ||| DT
decreased  ||| S:1378 E:1388 ||| JJ
actin  ||| S:1388 E:1394 ||| JJ
cytoskeleton  ||| S:1394 E:1407 ||| JJ
reorganization  ||| S:1407 E:1422 ||| NN
in  ||| S:1422 E:1425 ||| IN
response  ||| S:1425 E:1434 ||| NN
to  ||| S:1434 E:1437 ||| TO
LIMK2  ||| S:1437 E:1443 ||| CD
inhibition  ||| S:1443 E:1454 ||| NN
during  ||| S:1454 E:1461 ||| IN
FSS  ||| S:1461 E:1465 ||| NNP
increased  ||| S:1465 E:1475 ||| VBD
the  ||| S:1475 E:1479 ||| DT
mechanosensitivity  ||| S:1479 E:1498 ||| NN
of  ||| S:1498 E:1501 ||| IN
the  ||| S:1501 E:1505 ||| DT
osteoblasts ||| S:1505 E:1516 ||| NN
,  ||| S:1516 E:1518 ||| ,
based  ||| S:1518 E:1524 ||| VBN
on  ||| S:1524 E:1527 ||| IN
the  ||| S:1527 E:1531 ||| DT
increased  ||| S:1531 E:1541 ||| JJ
c-Fos  ||| S:1541 E:1547 ||| JJ
and  ||| S:1547 E:1551 ||| CC
COX-2  ||| S:1551 E:1557 ||| CD
expression  ||| S:1557 E:1568 ||| NN
as  ||| S:1568 E:1571 ||| IN
well  ||| S:1571 E:1576 ||| RB
as  ||| S:1576 E:1579 ||| IN
the  ||| S:1579 E:1583 ||| DT
enhanced  ||| S:1583 E:1592 ||| JJ
proliferative  ||| S:1592 E:1606 ||| JJ
activity  ||| S:1606 E:1615 ||| NN
in  ||| S:1615 E:1618 ||| IN
response  ||| S:1618 E:1627 ||| NN
to  ||| S:1627 E:1630 ||| TO
FSS ||| S:1630 E:1633 ||| NNP
.  ||| S:1633 E:1635 ||| .
These  ||| S:1635 E:1641 ||| DT
data  ||| S:1641 E:1646 ||| NNS
suggest  ||| S:1646 E:1654 ||| VBP
that  ||| S:1654 E:1659 ||| DT
osteoblasts  ||| S:1659 E:1671 ||| NN
can  ||| S:1671 E:1675 ||| MD
increase  ||| S:1675 E:1684 ||| VB
their  ||| S:1684 E:1690 ||| PRP$
mechanosensitivity  ||| S:1690 E:1709 ||| NN
under  ||| S:1709 E:1715 ||| IN
continuous  ||| S:1715 E:1726 ||| JJ
mechanical  ||| S:1726 E:1737 ||| JJ
stimulation  ||| S:1737 E:1749 ||| NN
by  ||| S:1749 E:1752 ||| IN
reducing  ||| S:1752 E:1761 ||| VBG
the  ||| S:1761 E:1765 ||| DT
actin  ||| S:1765 E:1771 ||| JJ
stress  ||| S:1771 E:1778 ||| NN
fiber  ||| S:1778 E:1784 ||| NN
formation  ||| S:1784 E:1794 ||| NN
through  ||| S:1794 E:1802 ||| IN
inhibiting  ||| S:1802 E:1813 ||| VBG
the  ||| S:1813 E:1817 ||| DT
LIMK2  ||| S:1817 E:1823 ||| JJ
expression ||| S:1823 E:1833 ||| NN
.  ||| S:1833 E:1835 ||| .
This  ||| S:1835 E:1840 ||| DT
study  ||| S:1840 E:1846 ||| NN
provides  ||| S:1846 E:1855 ||| VBZ
us  ||| S:1855 E:1858 ||| PRP
with  ||| S:1858 E:1863 ||| IN
a  ||| S:1863 E:1865 ||| DT
new  ||| S:1865 E:1869 ||| JJ
and  ||| S:1869 E:1873 ||| CC
more  ||| S:1873 E:1878 ||| RBR
specific  ||| S:1878 E:1887 ||| JJ
method  ||| S:1887 E:1894 ||| NN
to  ||| S:1894 E:1897 ||| TO
regulate  ||| S:1897 E:1906 ||| VB
the  ||| S:1906 E:1910 ||| DT
osteoblast  ||| S:1910 E:1921 ||| JJ
mechanosensitivity ||| S:1921 E:1939 ||| NN
,  ||| S:1939 E:1941 ||| ,
and  ||| S:1941 E:1945 ||| CC
also  ||| S:1945 E:1950 ||| RB
a  ||| S:1950 E:1952 ||| DT
new  ||| S:1952 E:1956 ||| JJ
therapeutic  ||| S:1956 E:1968 ||| JJ
target  ||| S:1968 E:1975 ||| NN
to  ||| S:1975 E:1978 ||| TO
cure  ||| S:1978 E:1983 ||| VB
bone  ||| S:1983 E:1988 ||| JJ
related  ||| S:1988 E:1996 ||| JJ
diseases ||| S:1996 E:2004 ||| NNS
,  ||| S:2004 E:2006 ||| ,
which  ||| S:2006 E:2012 ||| WDT
is  ||| S:2012 E:2015 ||| VBZ
of  ||| S:2015 E:2018 ||| IN
importance  ||| S:2018 E:2029 ||| NN
in  ||| S:2029 E:2032 ||| IN
maintaining  ||| S:2032 E:2044 ||| VBG
bone  ||| S:2044 E:2049 ||| NN
mass  ||| S:2049 E:2054 ||| NN
and  ||| S:2054 E:2058 ||| CC
promoting  ||| S:2058 E:2068 ||| VBG
osteogenesis ||| S:2068 E:2080 ||| NNS
.  ||| S:2080 E:2082 ||| .
